Imagin Medical Inc. (IMEXF)

[7Card]

Imagin will revolutionize early cancer detection.

Imagin Medical world class scientists are developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin's initial target market is bladder cancer, a major cancer worldwide, but will expand their product line with iVision and iRed. They will enable expansion into multiple endoscopic procedures, i.e., laparoscopic (general and gynecology), colorectal and thoracic
procedures related to cancer and non-cancerous conditions.

Imagin Medical CSE:IME is an opportunity to get in on the ground floor of a start up business, one having built a truly better 'mousetrap' - a technology that is a far superior product then the standard of care currently employed in an almost US$50bil global endoscope market.

http://imaginmedical.com/wp-content/uploads/2017/04/CORPORATE-PRESENTATION-4-1-17-Website.pdf